On March 9th, 2022, Colossal, a firm known for its aim to resurrect a wooly mammoth, raised US $60 million in Series A funding.
Untamed Planet, Animoca Brands, Breyer Capital, Animal Capital, Arch Ventures co-founder Robert Nelsen, Paris Hilton, Bold Capital, First Light Capital Group, Boost VC, Jazz Ventures, Builders VC, Green Sands Equity, Draper Associates, Charles Hoskinson, and others participated in an oversubscribed US $60 million Series A financing led by Thomas Tull and At One Ventures with participation from Untamed Planet and Animoca Brands.
What the founder has to say:
Colossal Biosciences – CEO Ben Lamm:
“As we approach the mammoth, our business goal is to develop these technologies that we believe will have broader applicability in human healthcare. The idea would be to spin out a few technologies to generate new revenue streams while balancing off spending from the massive experiment’s other limbs.”
“Through cutting-edge genetic technologies, we’re taking the globe one step closer to reversing the downward trend of environmental degradation and the catastrophic loss of biodiversity, paving the way for de-extinction and species preservation. Our mammoth restoration project’s technology and solutions will not only bring Arctic elephants back to the tundra but will also have broader consequences for conservation, science, and humanity.”
What the investors have to say:
“With this latest round of funding, Colossal is in a strong position to achieve long-awaited achievements that will aid in the restoration of healthy ecosystems. We will soon have the option of shifting from being a mindless murderer of the world’s species to being thoughtful kin to all life – Tom Chi of One Ventures (that led the funding round)
About Colossal Biosciences:
Colossal was created by Ben Lamm, an emerging technology and software entrepreneur, and George Church, Ph.D., a world-renowned geneticist, and serial biotech entrepreneur. Colossal develops revolutionary technology to restore extinct species, conserve severely endangered species, and repopulation of essential ecosystems that support life on Earth. The first to use CRISPR technology to save endangered animals, starting with the wooly mammoth. Colossal recognizes humanity’s responsibility to restore Earth to a healthier state while simultaneously addressing the human condition’s future economic and biological needs through cutting-edge science and technology.
We try our best to fact-check and bring the best, well-researched, and non-plagiarized content to you. Please let us know
-if there are any discrepancies in any of our published stories,
-how we can improve,
-what stories you would like us to cover and what information you are looking for, in the comments section below or through our contact form! We look forward to your feedback, and thank you for stopping by!
Next Article
